Simphotek, Inc. has been selected as one of 20 company Finalist to pitch to Onelin Capital and 400+ global early-stage investors Onelin Capital, A multi-billion dollar global conglomerate seeking startups in the life sciences Each company presented a 4-minute prerecorded pitch video, a 1-minute elevator-pitch, and participated in a live Q&A session with a panel of the sponsor and relevant investors.

Simphotek, Inc, a leading edge biotech company, developing noninvasive personalized products for treating internal solid tumors, was selected as a featured company and presented to a group of investors including MedPro Investors TiE Boston Angels Meda Angels Orange Grove Bio Accent Advisors